- Mitsubishi Chemical will transfer its 60% equity stake in Kaohsiung Monomer Company (KMC) to China Petrochemical Development Corporation (CPDC).
- KMC operates an ACH-method MMA monomer plant in Kaohsiung with annual capacity of 105,000 tons and capital of TWD 500 million.
- CPDC (40% owner) has capital of TWD 37,848,501,300 and reported net sales of TWD 19.2 billion in 2025, producing caprolactam and acrylonitrile.
- Transfer completion is scheduled for August 3, 2026, driven by intensifying Asian MMA competition and large-scale Chinese capacity expansion.
Transaction
Mitsubishi Chemical will transfer its entire 60% equity stake in Kaohsiung Monomer Company (KMC) to China Petrochemical Development Corporation (CPDC), dissolving the co-ownership of KMC.
Rationale
The move responds to intensifying MMA market competition in Asia and large-scale capacity expansion in China; Mitsubishi Chemical will consolidate production into more competitive locations and pursue entry into higher-growth markets.
KMC profile
KMC is based in Kaohsiung, Taiwan, established in 1976 with capital of TWD 500 million; it manufactures and sells MMA monomers via the ACH method with annual capacity of 105,000 tonnes and was owned 60% by Mitsubishi Chemical and 40% by CPDC.
CPDC profile and schedule
CPDC is headquartered in Kaohsiung, established in 1969 with capital of TWD 37,848,501,300 and reported net sales of TWD 19.2 billion in 2025, producing caprolactam and acrylonitrile; the transfer is scheduled to be completed by August 3, 2026.
